Home/Pipeline/IBD Multi-omics Dataset

IBD Multi-omics Dataset

Inflammatory Bowel Disease

CommercialActive

Key Facts

Indication

Inflammatory Bowel Disease

Phase

Commercial

Status

Active

Company

Ovation.io

About Ovation.io

Ovation.io operates at the intersection of digital health, AI/machine learning, and diagnostics, providing a critical data infrastructure layer for the precision medicine ecosystem. The company's core business involves curating and providing access to deeply phenotyped, disease-specific multi-omics data cohorts (e.g., for IBD, cardiometabolic diseases) to de-risk and accelerate therapeutic R&D for biopharma clients. Additionally, it offers a Laboratory Information Management System (Ovation LIMS) for clinical labs and operates a research network to mobilize remnant samples for research. Its strategy is validated through partnerships with major players like Illumina, DNAnexus, Datavant, and PrecisionLife.

View full company profile

Therapeutic Areas

Inflammatory Bowel Disease Cardiometabolic Disease Autoimmune Disease

Other Inflammatory Bowel Disease Drugs

Drug	Company	Phase	Status
Entyvio (vedolizumab)	Takeda Pharmaceutical	Commercial	Approved
Function-based Consortium for IBD	PharmaBiome	Pre-clinical	Active
Galapagos Collaboration	Scipher Medicine	Discovery/Pre-clinical	Active
TEV-‘574 (TL1A Inhibitor)	Teva	Phase 3	Active
IBD Subclassification	Bio-Me	Research	Active
Anti-iRhom2 antibodies	SciRhom	Pre-clinical	Active